Sunday, October 04, 2020
President Donald Trump is now being treated with dexamethasone, a common steroid that has demonstrated in clinical trials in the U.K. that it can reduce mortality in severely ill COVID-19 patients. Dexamethasone, a type of corticosteroid, has been considered a treatment only for severely ill COVID-19 patients; "corticosteroids also appear to be associated with benefit among critically ill patients with COVID-19 whether they are receiving mechanical ventilation or oxygen without mechanical ventilation," researchers wrote in September in a JAMA editorial.
Dexamethasone was beneficial for those who had been sick for more than a week, reducing deaths by one-third among patients on mechanical ventilators and by one-fifth among patients receiving supplemental oxygen by other means.
Patients given the steroid who were not receiving respiratory support, however, actually died at a slightly higher rate than similar patients who were not given the drug, although the difference was not statistically significant.
Admin's note: Participants in this discussion must follow the site's moderation policy. Profanity will be filtered. Abusive conduct is not allowed.